Centivax is a therapeutics company founded to create treatments ands cures to reduce and eradicate the remaining complex pathogens of the 21st century. The goal is to combine computational immuno-engineering to efficiently make break-through medicines.
Our computational engineering technologies were made possible by the emerging field of computational immunology, and developed by pioneers of that field over the course of 8 years. From our unique vantage point as the creators of these technologies, we were able to see that the true consequence of computational immunoengineering went far beyond disrupting the biologics discovery services market, and had broken open pathways to victory against many of the major outstanding druggability challenges in our generation of medicine.
Our computational engineering technologies were made possible by the emerging field of computational immunology, and developed by pioneers of that field over the course of 8 years. From our unique vantage point as the creators of these technologies, we were able to see that the true consequence of computational immunoengineering went far beyond disrupting the biologics discovery services market, and had broken open pathways to victory against many of the major outstanding druggability challenges in our generation of medicine.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2021
Main Therapeutic Focus:
Immunology
Lead Product in Development:
Broad-spectrum influenza vaccine
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
